Cargando…
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
BACKGROUND: Plasma ceramides and sphingomyelins have been independently linked to diabetes risk, glucose and insulin levels, and the risk of several cardiovascular (CVD) outcomes. However, whether individual ceramide and sphingomyelin species contribute to CVD risk among people with type 2 diabetes...
Autores principales: | Jensen, Paul N., Fretts, Amanda M., Hoofnagle, Andrew N., McKnight, Barbara, Howard, Barbara V., Umans, Jason G., Sitlani, Colleen M., Siscovick, David S., King, Irena B., Sotoodehnia, Nona, Lemaitre, Rozenn N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429431/ https://www.ncbi.nlm.nih.gov/pubmed/36042511 http://dx.doi.org/10.1186/s12933-022-01596-4 |
Ejemplares similares
-
Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study
por: Bockus, Lee B., et al.
Publicado: (2023) -
Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study
por: Jensen, Paul N., et al.
Publicado: (2020) -
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
por: Fretts, Amanda M., et al.
Publicado: (2021) -
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018) -
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)